Tan KT - Search Results

1

Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study.

Chiang NJ, Tan KT, Bai LY, Hsiao CF, Huang CY, Hung YP, Huang CJ, Chen SC, Shan YS, Chao Y, Huang YH, Lee IC, Lee PC, Su YY, Chen SJ, Yeh CN, Chen LT, Chen MH. Chiang NJ, et al. Among authors: tan kt. Clin Cancer Res. 2022 Oct 3;28(19):4248-4257. doi: 10.1158/1078-0432.CCR-22-1152. Clin Cancer Res. 2022. PMID: 35849151 Free PMC article. Clinical Trial.

2

Targeted next-generation sequencing reveals recurrence-associated genomic alterations in early-stage non-small cell lung cancer.

Cho WCS, Tan KT, Ma VWS, Li JYC, Ngan RKC, Cheuk W, Yip TTC, Yang YT, Chen SJ. Cho WCS, et al. Among authors: tan kt. Oncotarget. 2018 Nov 20;9(91):36344-36357. doi: 10.18632/oncotarget.26349. eCollection 2018 Nov 20. Oncotarget. 2018. PMID: 30555633 Free PMC article.

3

TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer.

Hsu HC, You JF, Chen SJ, Chen HC, Yeh CY, Tsai WS, Hung HY, Yang TS, Lapke N, Tan KT. Hsu HC, et al. Among authors: tan kt. Cancers (Basel). 2019 Jul 30;11(8):1079. doi: 10.3390/cancers11081079. Cancers (Basel). 2019. PMID: 31366114 Free PMC article.

4

Concomitant Genetic Alterations are Associated with Worse Clinical Outcome in EGFR Mutant NSCLC Patients Treated with Tyrosine Kinase Inhibitors.

Chang SC, Lai YC, Chang CY, Huang LK, Chen SJ, Tan KT, Yu PN, Lai JI. Chang SC, et al. Among authors: tan kt. Transl Oncol. 2019 Nov;12(11):1425-1431. doi: 10.1016/j.tranon.2019.07.008. Epub 2019 Aug 8. Transl Oncol. 2019. PMID: 31401335 Free PMC article.

5

Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.

Ong PY, Poon SL, Tan KT, Putti TC, Ow SGW, Chen SJ, Chen CH, Lee SC. Ong PY, et al. Among authors: tan kt. Gynecol Oncol. 2019 Nov;155(2):275-279. doi: 10.1016/j.ygyno.2019.08.027. Epub 2019 Aug 31. Gynecol Oncol. 2019. PMID: 31481248

6

Liquid Biopsy Detects Relapse Five Months Earlier than Regular Clinical Follow-Up and Guides Targeted Treatment in Breast Cancer.

Cheng FT, Lapke N, Wu CC, Lu YJ, Chen SJ, Yu PN, Liu YT, Tan KT. Cheng FT, et al. Among authors: tan kt. Case Rep Oncol Med. 2019 Sep 10;2019:6545298. doi: 10.1155/2019/6545298. eCollection 2019. Case Rep Oncol Med. 2019. PMID: 31583146 Free PMC article.

7

Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group.

Lai CH, Vallikad E, Lin H, Yang LY, Jung SM, Liu HE, Ou YC, Chou HH, Lin CT, Huang HJ, Huang KG, Qiu J, Hung YC, Wu TI, Chang WY, Tan KT, Lin CY, Chao A, Chang CJ. Lai CH, et al. Among authors: tan kt. J Gynecol Oncol. 2020 Jan;31(1):e5. doi: 10.3802/jgo.2020.31.e5. Epub 2019 Jul 26. J Gynecol Oncol. 2020. PMID: 31788995 Free PMC article. Clinical Trial.

8

Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab.

Tao CW, Chen MY, Tseng CM, Lapke N, Chen SJ, Tan KT. Tao CW, et al. Among authors: tan kt. Case Rep Oncol Med. 2020 Mar 1;2020:9072173. doi: 10.1155/2020/9072173. eCollection 2020. Case Rep Oncol Med. 2020. PMID: 32190395 Free PMC article.

9

Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report.

Hou TC, Wu PS, Huang WY, Yang YT, Tan KT, Liu SH, Chen YJ, Chen SJ, Su YW. Hou TC, et al. Among authors: tan kt. Medicine (Baltimore). 2020 Mar;99(12):e19577. doi: 10.1097/MD.0000000000019577. Medicine (Baltimore). 2020. PMID: 32195970 Free PMC article.

10

PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy.

Tan KT, Yeh CN, Chang YC, Cheng JH, Fang WL, Yeh YC, Wang YC, Hsu DS, Wu CE, Lai JI, Chang PM, Chen MH, Lu ML, Chen SJ, Chao Y, Hsiao M, Chen MH. Tan KT, et al. J Immunother Cancer. 2020 Mar;8(1):e000485. doi: 10.1136/jitc-2019-000485. J Immunother Cancer. 2020. PMID: 32238472 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

391 results

Search Page